Skip to main content
Premium Trial:

Request an Annual Quote

Becton Dickinson Posts 8-Percent Rise in Fiscal Q4 Revenue as Profit Increases 17 Percent

NEW YORK (GenomeWeb News) — Becton Dickinson today said fiscal fourth-quarter revenues were up almost 8 percent and profits were up 17 percent.
 
BD said total receipts for the three months ended Sept. 30 increased to $1.5 billion from $1.4 billion year over year.  
 
R&D spending for the period increased to $83.6 million from $76.6 million.
 
The company said net income for the period increased to $174 million from $149 million last year.
 
Becton Dickinson did not report its balance sheet for the quarter.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.